Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Pathology & Lab Medicine

Part 2: Nancy Simonian, MD Discusses Super-Enhancers

Super-Enhancers May Pave the Way for Future Cancer Therapies

Nancy Simonian, MD, CEO, Syros Pharmaceuticals details the research of Richard A. Young of the Whitehead Institute and his discovery of super-enhancers, large groups of transcriptional enhancers that drive expression of genes that define cell identity....
ABC News reports that Swedish scientists have identified a new strain of HIV that may be more harmful than existing strains. The findings, published in the Journal of Infectious Diseases, detail the discovery of A3/O2, a recombinant HIV strain known to...

Part 1: Nancy Simonian, MD on Targeting Gene Expression

Will Newly Discovered ‘Super-Enhancers’ Allow Us to Control Genes?

Nancy Simonian, MD, CEO, Syros Pharmaceuticals elaborates on the breakthrough discovery of super-enhancers, large groups of transcriptional enhancers that drive expression of genes that define cell identity. By identifying the most functionally important...